SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Home ▸ Executive Leadership ▸ Nilanjan Roy
Nilanjan Roy has deep experience in international finance as a result of his 33-year career in roles including Chief Financial Officer at Infosys Limited, Global Chief Financial Officer at Bharti Airtel Limited, and senior positions at Unilever. He has worked in a range of geographies in Europe, the United States and India.
Nilanjan’s broad expertise includes traditional finance functions such as treasury, mergers and acquisitions, investor relations, taxation, financial accounting, and reporting. Beyond this, his experience covers corporate governance, ESG (Environment, Social and Governance) and risk management. He has industry sector experience in information technology, telecommunications and consumer products.
Nilanjan holds a Bachelor of Commerce (Hons.) degree from Delhi University and is a Chartered Accountant. At Syngene, Nilanjan is the Chairperson of the Risk Management Committee and is a member of the Audit Committee and the Stakeholders Relationship & ESG Committee.
© 2025. Syngene International Limited